Taj Worldwide | Taj Group | Media | Career | FAQs | Feedback | contact us
 
Taj Logo
Phenobarbitone
 
Quality Medicines Api Generic Manufacturing For Doctors Brands Newsroom
 






 

 
HOME >> PRODUCTS >> Taj Products >> COA Download
Taj  ALL Products View Products According to Category

Phenobarbitone
 

Read the COA information for this product.



 
Read the COA ( Certificate of Analysis ) for this medication. (PDF)
      For more information, please see Full Prescribing Information.
 

PRECAUTIONS
General
Phenobarbital may be habit forming. Tolerance and psychological and physical dependence may occur with continuing use. (See ADVERSE REACTIONS: Drug Abuse and Dependence.) Phenobarbital should be administered with caution, if at all, to patients who are mentally depressed, have suicidal tendencies, or a history of drug abuse. Elderly or debilitated patients may react to Phenobarbital with marked excitement, depression, and confusion. In some persons, phenobarbital repeatedly produces excitement rather than depression.

In patients with hepatic damage, phenobarbital should be administered with caution and initially reduced doses. Phenobarbital should not be administered to patients showing the premonitory signs of hepatic coma.

Laboratory Tests
Prolonged therapy with phenobarbital should be accompanied by periodic laboratory evaluation of organ systems, including hematopoietic, renal, and hepatic systems (See General - above and ADVERSE REACTIONS.)

Carcinogenesis
Human-data: A retrospective study of 84 children with brain tumors matched to 73 normal controls and 78 cancer controls (malignant disease other than brain tumors) suggested an association between exposure to barbiturates prenatally and an increased incidence of brain tumors.

Pregnancy
Teratogenic effects: Pregnancy Category D. (See WARNINGS Use in Pregnancy.)

Nonteratogenic effects: Reports of infants suffering from long- term phenobarbital exposure in utero included the acute withdrawal syndrome of seizures and hyperirritability from birth to a delayed onset of up to 14 days. (See ADVERSE REACTIONS: Drug Abuse and Dependence.)

Labor and Delivery
Hypnotic doses of phenobarbital do not appear to significantly impair uterine activity during labor. Full anesthetic doses of phenobarbital decrease the force and frequency of uterine contractions. Administration of sedative-hypnotic phenobarbital to the mother during labor may result in respiratory depression in the newborn. Premature infants are particularly susceptible to the depressant effects of phenobarbital. If phenobarbital is used during labor and delivery, resuscitation equipment should be available.

Data are currently not available to evaluate the effect of phenobarbital on the later growth, development, and functional maturation of the child.

Nursing Mothers
Caution should be exercised when phenobarbital is administered to a nursing woman since small amounts of phenobarbital are excreted in the milk.

If you do not have the Acrobat Reader installed on your computer, download the plug-in and simply follow the instructions for installation. It is available without charge from Adobe®.com.

This link is provided as a convenience. Taj Pharma is not responsible for the content of this linked page.


 

 

 

Note : This product information is intended only for residents of the India. Taj Pharmaceuticals Limited,  medicines help to treat and prevent a range of conditions—from the most common to the most challenging—for people around the world.

Information for Health Care Professionals

*** Please consult local Prescribing Information for any product before use. This website is an international information resource for healthcare professionals with an interest in disease management. This website is not intended to replace the advice of a qualified healthcare professional. Above brand is a trademark of the Taj group of companies (Taj Pharmaceuticals Limited).

 

 

 

   CROPRAM ® Taj Products
Product Gallery
PDF Download
Doc Download
MSDS Download
COA Download
 Prescription Products (Rx)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 

 


 

 

 

 

 

 


 

 

Cropram™ Phenobarbital Tablets 15mg 30mg 60mg 100 mg manufacturers (PHENOBARBITAL) manufacturers Phenobarbital Manufacturer Patient Information Leaflet Phenobarbital Tablets 30mg 60mg Phenobarbital Tablets 30mg 60mg phenobarbital (phenobarbitone)  Phenobarbital Tablets 30mg 60mg History - Indications - Other uses - Side effects epilepsy phenobarbitone Phenobarbital tables phenobarbital sodium tablets of 15 30 60 and 100 mg phenobarbitone Importer Exporter Manufacturers Buyers Suppliers Importers and Exporters Phenobarbital CAS 50-06-6 phenobarbital wholesalers & distributorsPhenobarbital Sellers Phenobarbital Manufacturers Phenobarbital Exporters Phenobarbital WholesalersTreating and preventing seizures and treating sleep disorders – Taj Pharma India Cropram (PHENOBARBITAL) manufacturers Phenobarbital tables phenobarbital sodium tablets of 15 30 60 and 100 mg and suppliers Exporterphenobarbital phenobarbital products phenobarbital services phenobarbital information phenobarbital supplier Cropram™ (PHENOBARBITAL) Phenobarbital Tablets 15mg 30mg 60mg 100 mg manufacturers and suppliers Exporterphenobarbital phenobarbital products phenobarbital services phenobarbital information phenobarbital suppliers – Taj Pharma India phenobarbital sodium tablets of 15 30 60 and 100 mg PHENOBARBITAL phenobarbital phenobarbital products phenobarbitone phenobarbital services phenobarbital information phenobarbital suppliers phenobarbital manufacturers phenobarbital factory phenobarbital exporters phenobarbital importers phenobarbital buyers phenobarbital companiesPhenobarbital CAS 50-06  product supplier suppleir suppliers vendor vendors price prices phenobarbital manufacturers phenobarbital suppliersphenobarbital exporters wholesalers phenobarbital Distributors traders sellers import export trade leads sell offers selling leads

 
   
PRODUCTS
 
 
   
   
   
  india flag
  The Taj Pharmaceuticals Limited (Taj Group) has operations in every major international market
    AFRICA
  ASIA PACIFIC
  EUROPE
  MIDDLE EAST
  THAILAND
  BANGLADESH
  NORTH AMERICA
  SOUTH AMERICA
  RUSSIA
  NEWZELAND
  UNITED KINGDOM
 

`  

 

 

 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
 www.tajpharma.com

   

About Taj

Company

Products Diseases Health Divisions Media R & D Sustainability
Figure & Reports Investors

Countries

Brochure E-mail us Export & Import
Vacancies | C & F Agency | Distributor | Group Companies | History | Enquire Form | Countries | Pharma Technology
 Contact | Sitemap | User Terms and Conditions | Privacy and Cookie Statement